Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950133-05-004095
Filing Date
2005-09-09
Accepted
2005-09-09 15:36:36
Documents
2
Group Members
VENROCK ASSOCIATES III LPVENROCK ENTREPRENEURS FUND III LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 w12639sc13dza.htm SC 13D/A 51197
2 EXHIBIT 99.A w12639exv99wa.htm EX-99.A 2396
  Complete submission text file 0000950133-05-004095.txt   55669
Mailing Address 2950 WILDERNESS PLACE BOULDER CO 80301
Business Address 2950 WILDERNESS PLACE BOULDER CO 80301 3034496500
SIRNA THERAPEUTICS INC (Subject) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-47149 | Film No.: 051077713
SIC: 2834 Pharmaceutical Preparations

Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

EIN.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A